Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11651
PUT
Cadiz
CDZI
$334M
| $52.5K | ﹤0.01% |
+10,100
| New | +$36.4K |
|
11652
PUT
Larimar Therapeutics
LRMR
$421M
| $52.2K | ﹤0.01% |
13,500
-33,400
| -71% | -$220K |
|
|
CISO
11653
CISO Global
CISO
$10.2M
| $52.2K | ﹤0.01% |
15,030
+22
| +0.1% | +$27 |
|
11654
PUT
Solid Biosciences
SLDB
$1.09B
| $52K | ﹤0.01% |
13,000
-18,200
| -58% | -$100K |
|
11655
PUT
Ring Energy
REI
$383M
| $52K | ﹤0.01% |
38,200
-25,400
| -40% | -$38.1K |
|
11656
IRIDEX
IRIX
$12.4M
| $51.9K | ﹤0.01% |
30,869
-34,524
| -53% | -$56.9K |
|
|
BEST
11657
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $51.9K | ﹤0.01% |
19,566
+1,505
| +8% | +$4.04K |
|
|
LNAI
11658
Lunai Bioworks
LNAI
$10.7M
| $51.6K | ﹤0.01% |
772
+571
| +284% | +$37.9K |
|
|
AKYA
11659
CALL
DELISTED
Akoya BioSciences
AKYA
| $51.5K | ﹤0.01% |
+22,500
| New | +$59.6K |
|
11660
InflaRx
IFRX
$335M
| $51.5K | ﹤0.01% |
20,842
+8,468
| +68% | +$16.3K |
|
11661
1stdibs.com
DIBS
$146M
| $51.3K | ﹤0.01% |
14,502
-5,249
| -27% | -$21.2K |
|
|
ACCD
11662
CALL
DELISTED
Accolade Inc
ACCD
| $51.3K | ﹤0.01% |
15,000
-43,000
| -74% | -$153K |
|
|
LGO
11663
PUT
Largo
LGO
$75.4M
| $51.3K | ﹤0.01% |
+29,800
| New | +$60.9K |
|
11664
Satellogic
SATL
$816M
| $51.2K | ﹤0.01% |
+17,979
| New | +$32.9K |
|
11665
CALL
Entera Bio
ENTX
$533M
| $51.2K | ﹤0.01% |
+24,500
| New | +$45.7K |
|
|
DDL
11666
CALL
Dingdong
DDL
$488M
| $51.2K | ﹤0.01% |
+15,600
| New | +$60.3K |
|
11667
CareCloud
CCLD
$113M
| $51.1K | ﹤0.01% |
13,968
+3,968
| +40% | +$11.8K |
|
|
BGFV
11668
PUT
DELISTED
Big 5 Sporting Goods
BGFV
| $51K | ﹤0.01% |
28,500
-17,700
| -38% | -$32.4K |
|
11669
CALL
Precigen
PGEN
$2.57B
| $51K | ﹤0.01% |
45,500
-81,900
| -64% | -$69.9K |
|
|
TIXT
11670
CALL
DELISTED
TELUS International
TIXT
| $51K | ﹤0.01% |
13,000
-13,000
| -50% | -$49.2K |
|
11671
CALL
Globus Maritime Ltd
GLBS
$77.9M
| $50.9K | ﹤0.01% |
+43,500
| New | +$66.6K |
|
11672
FerroAtlántica
GSM
$757M
| $50.5K | ﹤0.01% |
13,278
-147,766
| -92% | -$634K |
|
11673
XBiotech
XBIT
$70.1M
| $50.4K | ﹤0.01% |
+12,768
| New | +$87K |
|
11674
Werewolf Therapeutics
HOWL
$47.2M
| $50.1K | ﹤0.01% |
+33,862
| New | +$69K |
|
|
CIF
11675
DELISTED
MFS Intermediate High Income Fund
CIF
| $49.8K | ﹤0.01% |
+28,790
| New | +$50.5K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.